{"transactions":[{"id":692885,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-07T20:23:00.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":43405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents a grant of options to purchase ordinary shares. This grant of options was approved by the Board on May 7, 2026, subject to (i) approval by the Company's shareholders, which was obtained on July 14, 2026 and (ii) the filing by the Company of a Registration Statement on Form S-8 registering the ordinary shares underlying the option grant, which occurred on August 7, 2026. The options vest on a quarterly basis over a one-year period that began on February 1, 2026, subject to full acceleration upon a Change in Control (as defined in the Plan)."}],"balance_after":43405,"derivative":{"exercise_price":1.37,"expiration_date":"2036-05-07","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":43405},"source":{"system":"sec-edgar","filing":"0001178913-26-003957","document":"zk2635885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000117891326003957/zk2635885.xml","form_type":"4"}},{"id":692884,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-07T20:23:00.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":33368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a grant of options to purchase ordinary shares. This grant of options was approved by the Board on May 7, 2026, subject to (i) approval by the Company's shareholders, which was obtained on July 14, 2026 and (ii) the filing by the Company of a Registration Statement on Form S-8 registering the ordinary shares underlying the option grant, which occurred on August 7, 2026. The options vest over a three year period which began on February 1, 2026, with one third of the options vesting on February 1, 2027 and the remaining two-thirds vesting ratably on a quarterly basis over the remaining two-year period, subject to full acceleration upon a Change in Control (as defined in the Company's 2018 Equity Incentive Plan (the \"Plan\"))."}],"balance_after":33368,"derivative":{"exercise_price":1.37,"expiration_date":"2036-05-07","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":33368},"source":{"system":"sec-edgar","filing":"0001178913-26-003957","document":"zk2635885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000117891326003957/zk2635885.xml","form_type":"4"}},{"id":692883,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-08-07T20:23:00.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":19117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Board of Directors (the \"Board\") of Entera Bio Ltd. (the \"Company\") awarded these shares to the Reporting Person in lieu of the cash fees the Reporting Person was entitled to for services rendered as a director of the Company for the first quarter and second quarter of 2026. This grant of shares was approved by the Board on August 5, 2026, subject to the filing by the Company of a Registration Statement on Form S-8 registering the shares, which occurred on August 7, 2026."}],"balance_after":34117,"source":{"system":"sec-edgar","filing":"0001178913-26-003957","document":"zk2635885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000117891326003957/zk2635885.xml","form_type":"4"}},{"id":702519,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2026-07-28T20:21:14.000Z","date":"2026-07-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":53266,"price":1.22,"value":64984.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents shares of common stock par value $0.01 per shares of OPKO Health, Inc. withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."}],"balance_after":6571966,"source":{"system":"sec-edgar","filing":"0001193125-26-321041","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000119312526321041/ownership.xml","form_type":"4"}},{"id":725287,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T21:55:57.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":31746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 24, 2027."}],"balance_after":31746,"derivative":{"exercise_price":3.45,"exercise_date":"2027-06-24","expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":31746},"source":{"system":"sec-edgar","filing":"0001381874-26-000001","document":"wk-form4_1782510955.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000138187426000001/wk-form4_1782510955.xml","form_type":"4"}},{"id":743625,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T00:00:53.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":4018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 24 substantially equal monthly installments so that the option will be fully vested and exercisable on the second anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date."}],"balance_after":4018,"derivative":{"exercise_price":11,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":4018},"source":{"system":"sec-edgar","filing":"0001193125-26-266275","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526266275/ownership.xml","form_type":"4"}},{"id":747593,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:57:53.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":2179,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 4, 2026, the reporting person received a grant of 2,179 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vests on the earlier of one year from the date of grant or the 2027 annual meeting of stockholders, subject to accelerated vesting under certain conditions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 4, 2026, the reporting person received a grant of 2,179 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vests on the earlier of one year from the date of grant or the 2027 annual meeting of stockholders, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 4, 2026, the reporting person received a grant of 2,179 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vests on the earlier of one year from the date of grant or the 2027 annual meeting of stockholders, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,600 RSUs originally granted on November 30, 2023, convertible into common stock of the issuer on a one-for-one basis, which vests on December 1, 2026, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 5,333 RSUs originally granted on November 4, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 59,200 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 4,450 RSUs originally granted on December 19, 2025, convertible into common stock of the issuer on a one-for-one basis, which vests in three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain circumstances."}],"balance_after":147767,"source":{"system":"sec-edgar","filing":"0001193125-26-259844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000119312526259844/ownership.xml","form_type":"4"}},{"id":787292,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T21:12:24.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested as to 50% on the first anniversary of January 24, 2024 and the remaining amount vested in two equal annual installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested as to 50% on the first anniversary of January 24, 2024 and the remaining amount vested in two equal annual installments thereafter."}],"balance_after":1875,"derivative":{"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001193125-26-214983","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214983/ownership.xml","form_type":"4"}},{"id":787291,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T21:12:24.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":179854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 1/36 on October 31, 2025, with the remaining options vesting thereafter in equal consecutive monthly increments for 35 months, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date."}],"balance_after":179854,"derivative":{"exercise_price":0.15,"expiration_date":"2035-09-19","underlying":"Common Stock","underlying_shares":179854},"source":{"system":"sec-edgar","filing":"0001193125-26-214983","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214983/ownership.xml","form_type":"4"}},{"id":787290,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-08T21:12:24.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":true,"shares":1875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001193125-26-214983","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214983/ownership.xml","form_type":"4"}},{"id":900447,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-02-17T13:30:51.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.49,"value":7450.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001178913-26-000508","document":"zk2634371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000117891326000508/zk2634371.xml","form_type":"4"}},{"id":909600,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-02-11T13:44:25.000Z","date":"2026-02-09","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.2,"value":12000.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001178913-26-000412","document":"zk2634333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000117891326000412/zk2634333.xml","form_type":"4"}},{"id":939998,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-13T21:10:01.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":16410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Compensation Committee of the Board of Directors. The non-qualified stock options are granted under the Issuer's 2025 Equity Incentive Plan and the exercisability shall be subject to execution of the Issuer's form of Non-Qualified Stock Option Agreement. The non-qualified stock options shall vest as follows: one-half shall vest and become exercisable on January 9, 2027 and the remaining half shall vest and become exercisable in eight equal quarterly installments commencing on March 31, 2027, subject to the Reporting Person continuing to serve as a director of the Issuer on each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Compensation Committee of the Board of Directors. The non-qualified stock options are granted under the Issuer's 2025 Equity Incentive Plan and the exercisability shall be subject to execution of the Issuer's form of Non-Qualified Stock Option Agreement. The non-qualified stock options shall vest as follows: one-half shall vest and become exercisable on January 9, 2027 and the remaining half shall vest and become exercisable in eight equal quarterly installments commencing on March 31, 2027, subject to the Reporting Person continuing to serve as a director of the Issuer on each applicable vesting date."}],"balance_after":16410,"derivative":{"exercise_price":1.1,"expiration_date":"2036-01-09","underlying":"Common Stock","underlying_shares":16410},"source":{"system":"sec-edgar","filing":"0001493152-26-002033","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315226002033/ownership.xml","form_type":"4"}},{"id":960723,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-22T23:52:24.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":4450,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 19, 2025, the reporting person received a grant of 4,450 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain conditions. The RSU grant includes an award of 2,130 RSUs for serving as a member of the Company's Board of Directors, 1,625 RSUs for serving as a member of the Audit Committee and 695 RSUs for serving as the Chair of the Compensation Committee."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 19, 2025, the reporting person received a grant of 4,450 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain conditions. The RSU grant includes an award of 2,130 RSUs for serving as a member of the Company's Board of Directors, 1,625 RSUs for serving as a member of the Audit Committee and 695 RSUs for serving as the Chair of the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On December 19, 2025, the reporting person received a grant of 4,450 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain conditions. The RSU grant includes an award of 2,130 RSUs for serving as a member of the Company's Board of Directors, 1,625 RSUs for serving as a member of the Audit Committee and 695 RSUs for serving as the Chair of the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,600 RSUs originally granted on November 30, 2023, convertible into common stock of the issuer on a one-for-one basis, which vests on December 1, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 5,333 RSUs originally granted on November 4, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 59,200 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability."}],"balance_after":145588,"source":{"system":"sec-edgar","filing":"0001193125-25-329097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000119312525329097/ownership.xml","form_type":"4"}},{"id":1101544,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T00:29:27.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 24, 2026."}],"balance_after":20000,"derivative":{"exercise_price":14.13,"exercise_date":"2026-06-24","expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-25-033063","document":"wk-form4_1750897763.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000162828025033063/wk-form4_1750897763.xml","form_type":"4"}},{"id":1131023,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-29T21:04:22.000Z","date":"2025-05-27","kind":"grant","planned":false,"acquired":true,"shares":437500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning May 27, 2026."}],"balance_after":437500,"derivative":{"exercise_price":1.31,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":437500},"source":{"system":"sec-edgar","filing":"0000950170-25-079112","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017025079112/ownership.xml","form_type":"4"}},{"id":1194488,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-21T22:30:08.000Z","date":"2025-03-19","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":38.93,"value":389300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $38.89 to $38.96, inclusive, with a weighted average price per share of $38.93. The reporting person undertakes to provide Red Violet, Inc., any security holder of Red Violet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,000 Restricted Stock Units (\"RSUs\"), originally granted on November 4, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests in approximately three equal installments on each of November 1, 2025, November 1, 2026, and November 1, 2027, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 7,200 RSUs originally granted on November 30, 2023, convertible into common stock of the issuer on a one-for-one basis, which vests in approximately two equal installments on each of December 1, 2025, and December 1, 2026, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 3,600 RSUs originally granted on October 12, 2022, convertible into common stock of the issuer on a one-for-one basis, which vests on November 1, 2025, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 55,600 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability."}],"balance_after":141138,"source":{"system":"sec-edgar","filing":"0000950170-25-043394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000095017025043394/ownership.xml","form_type":"4"}},{"id":1293348,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-28T22:36:23.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001104659-25-006783","document":"tm254730-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465925006783/tm254730-3_4seq1.xml","form_type":"4"}},{"id":1293347,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-28T22:36:23.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15750,"source":{"system":"sec-edgar","filing":"0001104659-25-006783","document":"tm254730-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465925006783/tm254730-3_4seq1.xml","form_type":"4"}},{"id":1375095,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T23:53:08.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 4, 2024, the reporting person received a grant of 8,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of November 1, 2025, November 1, 2026, and November 1, 2027, subject to accelerated vesting under certain conditions. The RSU grant includes an award of 3,760 RSUs for serving as a member of the Company's Board of Directors, 2,960 RSUs for serving as a member of the Audit Committee and 1,280 RSUs for serving as the Chair of the Compensatio Committee."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2024, the reporting person received a grant of 8,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of November 1, 2025, November 1, 2026, and November 1, 2027, subject to accelerated vesting under certain conditions. The RSU grant includes an award of 3,760 RSUs for serving as a member of the Company's Board of Directors, 2,960 RSUs for serving as a member of the Audit Committee and 1,280 RSUs for serving as the Chair of the Compensatio Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 4, 2024, the reporting person received a grant of 8,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of November 1, 2025, November 1, 2026, and November 1, 2027, subject to accelerated vesting under certain conditions. The RSU grant includes an award of 3,760 RSUs for serving as a member of the Company's Board of Directors, 2,960 RSUs for serving as a member of the Audit Committee and 1,280 RSUs for serving as the Chair of the Compensatio Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,800 RSUs originally granted on November 30, 2023, convertible into common stock of the issuer on a one-for-one basis, which vests in approximately three equal installments on each of December 1, 2024, December 1, 2025, and December 1, 2026, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,600 RSUs originally granted on October 12, 2022, convertible into common stock of the issuer on a one-for-one basis, which vests on November 1, 2025, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 55,600 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability."}],"balance_after":151138,"source":{"system":"sec-edgar","filing":"0000950170-24-121713","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000095017024121713/ownership.xml","form_type":"4"}},{"id":1385138,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-17T20:01:36.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This restricted stock grant was made pursuant to the Issuer's 2018 Equity Incentive Plan and vests as to 50% of the shares on October 16, 2025 and in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001104659-24-109523","document":"tm2426349-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465924109523/tm2426349-3_4seq1.xml","form_type":"4"}},{"id":1387509,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-11T20:05:58.000Z","date":"2024-10-09","kind":"grant","planned":false,"acquired":true,"shares":18957,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by the Board of Directors of the Issuer. One half of the RSUs are fully vested, with the balance vesting in eight equal quarterly installments on the last day of each quarter commencing with the quarter ending September 30, 2025, subject to continued services for the Company as of each applicable vesting date. Shares of common stock will be delivered to the Reporting Person promptly upon vesting, unless the Reporting Person elects to defer delivery. The RSUs were granted under the Issuer's 2015 Equity Incentive Plan and will vest in full upon a Change of Control as defined in such Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by the Board of Directors of the Issuer. One half of the RSUs are fully vested, with the balance vesting in eight equal quarterly installments on the last day of each quarter commencing with the quarter ending September 30, 2025, subject to continued services for the Company as of each applicable vesting date. Shares of common stock will be delivered to the Reporting Person promptly upon vesting, unless the Reporting Person elects to defer delivery. The RSUs were granted under the Issuer's 2015 Equity Incentive Plan and will vest in full upon a Change of Control as defined in such Plan."}],"balance_after":2660242,"source":{"system":"sec-edgar","filing":"0001493152-24-040905","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315224040905/ownership.xml","form_type":"4"}},{"id":1448290,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2024-07-26T23:11:51.000Z","date":"2024-07-24","kind":"grant","planned":false,"acquired":true,"shares":437500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OPKO common stock upon the vesting of the award. The\nrestricted stock units vest 50% on the second anniversary of the grant date, then 25% on each of the following two years."}],"balance_after":6625232,"source":{"system":"sec-edgar","filing":"0000950170-24-087034","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024087034/ownership.xml","form_type":"4"}},{"id":1470423,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-24T21:45:01.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 20, 2025."}],"balance_after":20000,"derivative":{"exercise_price":2.71,"exercise_date":"2025-06-20","expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-24-029653","document":"wk-form4_1719265494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000162828024029653/wk-form4_1719265494.xml","form_type":"4"}},{"id":1669875,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-01-26T21:33:02.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-24-007293","document":"tm244260-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465924007293/tm244260-3_4seq1.xml","form_type":"4"}},{"id":1686266,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2024-01-05T18:39:36.000Z","date":"2024-01-05","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.8669,"value":8669.0,"ownership":{"direct":true},"balance_after":6187732,"source":{"system":"sec-edgar","filing":"0000950170-24-002380","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024002380/ownership.xml","form_type":"4"}},{"id":1723518,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-04T23:30:08.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":10800,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2023, the reporting person received a grant of 10,800 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of December 1, 2024, December 1, 2025 and December 1, 2026, subject to accelerated vesting under certain conditions. The RSU grant includes an award of 5,000 RSUs for serving as a member of the Company's Board of Directors, 4,000 RSUs for serving on the Audit Committee and 1,800 RSUs for serving as the Chair of the Compensation Committee."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 30, 2023, the reporting person received a grant of 10,800 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of December 1, 2024, December 1, 2025 and December 1, 2026, subject to accelerated vesting under certain conditions. The RSU grant includes an award of 5,000 RSUs for serving as a member of the Company's Board of Directors, 4,000 RSUs for serving on the Audit Committee and 1,800 RSUs for serving as the Chair of the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2023, the reporting person received a grant of 10,800 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of December 1, 2024, December 1, 2025 and December 1, 2026, subject to accelerated vesting under certain conditions. The RSU grant includes an award of 5,000 RSUs for serving as a member of the Company's Board of Directors, 4,000 RSUs for serving on the Audit Committee and 1,800 RSUs for serving as the Chair of the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,966 RSUs convertible into common stock originally granted on September 24, 2021. The RSUs vest on October 1, 2024, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 7,200 RSUs originally granted on October 12, 2022. The RSUs vest in approximately two equal installments on each of November 1, 2024, and November 1, 2025, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 49,034 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability."}],"balance_after":143138,"source":{"system":"sec-edgar","filing":"0001209191-23-057303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000120919123057303/doc4.xml","form_type":"4"}},{"id":1744675,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2023-11-13T13:21:00.000Z","date":"2023-11-10","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.3,"value":13000.0,"ownership":{"direct":true},"balance_after":6177732,"source":{"system":"sec-edgar","filing":"0001209191-23-054917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123054917/doc4.xml","form_type":"4"}},{"id":1825669,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-07-20T20:05:17.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":17233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 18, 2024 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2024, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date."}],"balance_after":17233,"derivative":{"exercise_price":2.67,"expiration_date":"2033-07-18","underlying":"Common Stock","underlying_shares":17233},"source":{"system":"sec-edgar","filing":"0001493152-23-025078","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315223025078/ownership.xml","form_type":"4"}},{"id":1851624,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T21:28:03.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 15, 2024."}],"balance_after":20000,"derivative":{"exercise_price":1.67,"exercise_date":"2024-06-15","expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-23-022537","document":"wk-form4_1686950874.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000162828023022537/wk-form4_1686950874.xml","form_type":"4"}},{"id":1874340,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T20:13:28.000Z","date":"2023-05-25","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":1.46,"value":10220.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001628280-23-020112","document":"wk-form4_1685477593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000162828023020112/wk-form4_1685477593.xml","form_type":"4"}},{"id":1885620,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-19T20:37:43.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning May 18, 2024."}],"balance_after":700000,"derivative":{"exercise_price":1.58,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001209191-23-031034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123031034/doc4.xml","form_type":"4"}},{"id":2040582,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-01-31T21:09:58.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 50% of the underlying shares on the first anniversary of January 30, 2023, and the remaining 50% of the underlying shares will vest in twelve (12) equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date."}],"balance_after":2859,"derivative":{"exercise_price":4,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001104659-23-008601","document":"tm234943-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465923008601/tm234943-3_4seq1.xml","form_type":"4"}},{"id":2137550,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-13T22:56:54.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":10800,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 12, 2022, the reporting person received a grant of 10,800 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of November 1, 2023, November 1, 2024 and November 1, 2025, subject to accelerated vesting under certain conditions.  The RSU grant includes an award of 5,000 RSUs for serving as a member of the Company's Board of Directors, 4,000 RSUs for serving on the Audit Committee and 1,800 RSUs for serving as the Chair of the Compensation Committee."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 12, 2022, the reporting person received a grant of 10,800 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of November 1, 2023, November 1, 2024 and November 1, 2025, subject to accelerated vesting under certain conditions.  The RSU grant includes an award of 5,000 RSUs for serving as a member of the Company's Board of Directors, 4,000 RSUs for serving on the Audit Committee and 1,800 RSUs for serving as the Chair of the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On October 12, 2022, the reporting person received a grant of 10,800 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of November 1, 2023, November 1, 2024 and November 1, 2025, subject to accelerated vesting under certain conditions.  The RSU grant includes an award of 5,000 RSUs for serving as a member of the Company's Board of Directors, 4,000 RSUs for serving on the Audit Committee and 1,800 RSUs for serving as the Chair of the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,933 RSUs convertible into common stock originally granted on September 24, 2021. The RSUs vest in approximately two equal installments on October 1, 2023 and October 1, 2024, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 4,666 RSUs originally granted on November 20, 2020.  The RSUs vest in approximately two equal installments on each of November 1, 2022, and November 1, 2023, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 37,801 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability."}],"balance_after":132338,"source":{"system":"sec-edgar","filing":"0001209191-22-053609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000120919122053609/doc4.xml","form_type":"4"}},{"id":2195555,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-08-03T20:02:59.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":188000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 25, 2023 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2023, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date."}],"balance_after":188000,"derivative":{"exercise_price":0.42,"expiration_date":"2032-07-25","underlying":"Common Stock","underlying_shares":188000},"source":{"system":"sec-edgar","filing":"0001493152-22-021149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315222021149/ownership.xml","form_type":"4"}},{"id":2225053,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T23:10:27.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 16, 2023."}],"balance_after":20000,"derivative":{"exercise_price":1.64,"exercise_date":"2023-06-16","expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-22-017724","document":"wf-form4_165585300854193.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000162828022017724/wf-form4_165585300854193.xml","form_type":"4"}},{"id":2228489,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-17T12:27:49.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 50% of the underlying shares on June 15, 2023 and the remainder in twelve (12) equal monthly installments thereafter."}],"balance_after":20000,"derivative":{"exercise_price":0.26,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-072187","document":"tm2218714-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465922072187/tm2218714-5_4seq1.xml","form_type":"4"}},{"id":2558653,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-27T22:30:52.000Z","date":"2021-09-24","kind":"grant","acquired":true,"shares":8900,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 24, 2021, the reporting person received a grant of 8,900 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of October 1, 2022, October 1, 2023 and October 1, 2024, subject to accelerated vesting under certain conditions.  The RSU grant includes an award of 2,400 RSUs for serving as a member of the Company's Board of Directors, 5,000 RSUs for serving on the Audit Committee and 1,500 RSUs for serving as the Chair of the Compensation Committee."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 24, 2021, the reporting person received a grant of 8,900 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of October 1, 2022, October 1, 2023 and October 1, 2024, subject to accelerated vesting under certain conditions.  The RSU grant includes an award of 2,400 RSUs for serving as a member of the Company's Board of Directors, 5,000 RSUs for serving on the Audit Committee and 1,500 RSUs for serving as the Chair of the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On September 24, 2021, the reporting person received a grant of 8,900 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of October 1, 2022, October 1, 2023 and October 1, 2024, subject to accelerated vesting under certain conditions.  The RSU grant includes an award of 2,400 RSUs for serving as a member of the Company's Board of Directors, 5,000 RSUs for serving on the Audit Committee and 1,500 RSUs for serving as the Chair of the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,166 RSUs convertible into common stock originally granted on October 28, 2019. The RSUs vest on September 1, 2022, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 7,000 RSUs originally granted on November 20, 2020.  The RSUs vest in approximately three equal installments on each of November 1, 2021, November 1, 2022, and November 1, 2023, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 28,334 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability."}],"balance_after":121538,"source":{"system":"sec-edgar","filing":"0001209191-21-057836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000120919121057836/doc4.xml","form_type":"4"}},{"id":2629137,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-07-20T20:05:54.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":88000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 16, 2022 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date."}],"balance_after":88000,"derivative":{"exercise_price":1.11,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":88000},"source":{"system":"sec-edgar","filing":"0001493152-21-017326","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315221017326/ownership.xml","form_type":"4"}},{"id":2658476,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-06-22T21:27:03.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 100% on June 17, 2022"}],"balance_after":20000,"derivative":{"exercise_price":9.99,"exercise_date":"2022-06-17","expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-21-012673","document":"wf-form4_162439717162695.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000162828021012673/wf-form4_162439717162695.xml","form_type":"4"}},{"id":2703639,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T20:10:27.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests as follows: one half (1/2) of the shares underlying the option shall vest on May 19, 2022 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":1.48,"expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-21-002609","document":"form4-05202021_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921002609/form4-05202021_040501.xml","form_type":"4"}},{"id":2844238,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-22T21:10:09.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning February 19, 2022."}],"balance_after":350000,"derivative":{"exercise_price":4.81,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-21-012670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919121012670/doc4.xml","form_type":"4"}},{"id":2967646,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-24T22:00:56.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 20, 2020, the reporting person received a grant of 7,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuance on a one-for-one basis, which vest in approximately three equal installments on each of November 1, 2021, November 1, 2022, and November 1, 2023, subject to accelerated vesting under certain conditions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 20, 2020, the reporting person received a grant of 7,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuance on a one-for-one basis, which vest in approximately three equal installments on each of November 1, 2021, November 1, 2022, and November 1, 2023, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 20, 2020, the reporting person received a grant of 7,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuance on a one-for-one basis, which vest in approximately three equal installments on each of November 1, 2021, November 1, 2022, and November 1, 2023, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,333 RSUs convertible into common stock originally granted on October 28, 2019. The RSUs vest in two equal installments on each of September 1, 2021 and September 1, 2022, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 8,333 RSUs convertible into common stock originally granted subject to both certain performance- and time-based criteria on September 5, 2018. As of June 30, 2019, the issuer deemed the performance criteria had been met. As a result of the meeting the performance criteria, the remaining RSUs vest on July 1, 2021, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 4,000 RSUs convertible into common stock originally granted on March 29, 2018. The RSUs vest on March 29, 2021, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 20,167 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability."}],"balance_after":112638,"source":{"system":"sec-edgar","filing":"0001209191-20-060253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000120919120060253/doc4.xml","form_type":"4"}},{"id":3045829,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2020-08-27T12:40:54.000Z","date":"2020-08-26","kind":"purchase","acquired":true,"shares":2500,"price":4.01,"value":10025.0,"ownership":{"direct":true},"balance_after":6167732,"source":{"system":"sec-edgar","filing":"0001209191-20-048491","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919120048491/doc4.xml","form_type":"4"}},{"id":3045828,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2020-08-27T12:40:54.000Z","date":"2020-08-26","kind":"purchase","acquired":true,"shares":2500,"price":3.9872,"value":9968.0,"ownership":{"direct":true},"balance_after":6165232,"source":{"system":"sec-edgar","filing":"0001209191-20-048491","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919120048491/doc4.xml","form_type":"4"}},{"id":3045827,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2020-08-27T12:40:54.000Z","date":"2020-08-26","kind":"purchase","acquired":true,"shares":5000,"price":3.99,"value":19950.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 413,585 shares received as a pro rata distribution from The Frost Group, LLC (\"The Frost Group\"), of which the reporting person is a member. The Frost Group effected a pro rata distribution of its 20,091,062 shares of the Issuer, pursuant to which reporting person now has direct beneficial ownership of his pro rata share of the securities formerly held by The Frost Group. The reporting person previously reported that the shares were owned directly by The Frost Group."}],"balance_after":6162732,"source":{"system":"sec-edgar","filing":"0001209191-20-048491","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919120048491/doc4.xml","form_type":"4"}},{"id":3100772,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-06-24T20:05:28.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: 36,000 stock options will vest on the one year anniversary of the grant date and the remaining 36,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021."}],"balance_after":72000,"derivative":{"exercise_price":1.33,"expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001493152-20-011715","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315220011715/ownership.xml","form_type":"4"}},{"id":3101670,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2020-06-24T00:42:53.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 100% on June 19, 2021."}],"balance_after":20000,"derivative":{"exercise_price":4.67,"exercise_date":"2021-06-19","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-20-001675","document":"form4-06232020_050639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000141588920001675/form4-06232020_050639.xml","form_type":"4"}},{"id":3119240,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-08T20:14:16.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning June 4, 2021."}],"balance_after":350000,"derivative":{"exercise_price":2.27,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-20-034960","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919120034960/doc4.xml","form_type":"4"}},{"id":3135573,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-26T19:03:44.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests as follows: one half (1/2) of the shares underlying the option shall vest on May 20, 2021 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":3.39,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-20-001337","document":"form4-05262020_120530.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920001337/form4-05262020_120530.xml","form_type":"4"}},{"id":3385267,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-30T21:35:12.000Z","date":"2019-10-28","kind":"grant","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 28, 2019, the reporting person received a grant of 12,500 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in three equal installments on each of September 1, 2020, September 1, 2021 and September 1, 2022, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On October 28, 2019, the reporting person received a grant of 12,500 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis, which vest in three equal installments on each of September 1, 2020, September 1, 2021 and September 1, 2022, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,666 RSUs convertible into common stock originally granted subject to both certain performance and time-based criteria on September 5, 2018.  As of June 30, 2019, the issuer deemed the performance criteria had been met.  As a result of the meeting the performance criteria, the remaining RSUs vest in two equal installments on each of July 1, 2020 and July 1, 2021, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 8,000 RSUs convertible into common stock originally granted on March 29, 2018.  The RSUs vest in two equal installments on each of March 29, 2020 and March 29, 2021, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 12,000 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability."}],"balance_after":105638,"source":{"system":"sec-edgar","filing":"0001209191-19-054537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000120919119054537/doc4.xml","form_type":"4"}},{"id":3388089,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2019-10-25T18:46:30.000Z","date":"2019-10-25","kind":"purchase","acquired":true,"shares":15000,"price":1.5,"value":22500.0,"ownership":{"direct":true},"balance_after":5744147,"source":{"system":"sec-edgar","filing":"0001209191-19-054073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119054073/doc4.xml","form_type":"4"}},{"id":3388037,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-25T18:05:48.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning July 1, 2020."}],"balance_after":250000,"derivative":{"exercise_price":2.47,"expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-19-054064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119054064/doc4.xml","form_type":"4"}},{"id":3395226,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-09T20:40:59.000Z","date":"2019-10-08","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 8, 2019, Rook Merger Sub, Inc. (\"Purchaser\"), a wholly owned subsidiary of Austin, Nichols & Co., Inc. (\"Parent\"), successfully completed the tender offer (\"Tender Offer\") for all issued and outstanding shares of the common stock of Castle Brands Inc. (\"Issuer\") pursuant to that certain Agreement and Plan of Merger, dated August 28, 2019 (the \"Merger Agreement\"), by and among Issuer, Parent and Purchaser. Following the Tender Offer, on October 9, 2019, Purchaser merged with and into Issuer with Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, the reporting person is no longer a director of Issuer, effective on October 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, this stock option held by the reporting person was deemed to be fully vested and cancelled and converted at the effective time of the Merger into the right to receive a cash payment, without interest, equal to the product of (i) the aggregate number of shares of the Issuer's Common Stock subject to such stock option multiplied by (ii) the excess of $1.27 over the per share exercise price of such stock option, less any taxes required to be withheld."}],"balance_after":0,"derivative":{"exercise_price":1.04,"exercise_date":"2018-02-28","expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-052883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919119052883/doc4.xml","form_type":"4"}},{"id":3395225,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-09T20:40:59.000Z","date":"2019-10-08","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 8, 2019, Rook Merger Sub, Inc. (\"Purchaser\"), a wholly owned subsidiary of Austin, Nichols & Co., Inc. (\"Parent\"), successfully completed the tender offer (\"Tender Offer\") for all issued and outstanding shares of the common stock of Castle Brands Inc. (\"Issuer\") pursuant to that certain Agreement and Plan of Merger, dated August 28, 2019 (the \"Merger Agreement\"), by and among Issuer, Parent and Purchaser. Following the Tender Offer, on October 9, 2019, Purchaser merged with and into Issuer with Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, the reporting person is no longer a director of Issuer, effective on October 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, this stock option held by the reporting person was deemed to be fully vested and cancelled and converted at the effective time of the Merger into the right to receive a cash payment, without interest, equal to the product of (i) the aggregate number of shares of the Issuer's Common Stock subject to such stock option multiplied by (ii) the excess of $1.27 over the per share exercise price of such stock option, less any taxes required to be withheld."}],"balance_after":0,"derivative":{"exercise_price":0.84,"exercise_date":"2017-03-17","expiration_date":"2026-03-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-052883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919119052883/doc4.xml","form_type":"4"}},{"id":3395224,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-09T20:40:59.000Z","date":"2019-10-08","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 8, 2019, Rook Merger Sub, Inc. (\"Purchaser\"), a wholly owned subsidiary of Austin, Nichols & Co., Inc. (\"Parent\"), successfully completed the tender offer (\"Tender Offer\") for all issued and outstanding shares of the common stock of Castle Brands Inc. (\"Issuer\") pursuant to that certain Agreement and Plan of Merger, dated August 28, 2019 (the \"Merger Agreement\"), by and among Issuer, Parent and Purchaser. Following the Tender Offer, on October 9, 2019, Purchaser merged with and into Issuer with Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, the reporting person is no longer a director of Issuer, effective on October 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, this stock option was cancelled at the effective time of the Merger because the exercise price of the stock option exceeded $1.27 per share."}],"balance_after":0,"derivative":{"exercise_price":1.46,"exercise_date":"2016-03-26","expiration_date":"2025-03-26","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-052883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919119052883/doc4.xml","form_type":"4"}},{"id":3395223,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-09T20:40:59.000Z","date":"2019-10-08","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 8, 2019, Rook Merger Sub, Inc. (\"Purchaser\"), a wholly owned subsidiary of Austin, Nichols & Co., Inc. (\"Parent\"), successfully completed the tender offer (\"Tender Offer\") for all issued and outstanding shares of the common stock of Castle Brands Inc. (\"Issuer\") pursuant to that certain Agreement and Plan of Merger, dated August 28, 2019 (the \"Merger Agreement\"), by and among Issuer, Parent and Purchaser. Following the Tender Offer, on October 9, 2019, Purchaser merged with and into Issuer with Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, the reporting person is no longer a director of Issuer, effective on October 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, this stock option held by the reporting person was deemed to be fully vested and cancelled and converted at the effective time of the Merger into the right to receive a cash payment, without interest, equal to the product of (i) the aggregate number of shares of the Issuer's Common Stock subject to such stock option multiplied by (ii) the excess of $1.27 over the per share exercise price of such stock option, less any taxes required to be withheld."}],"balance_after":0,"derivative":{"exercise_price":1.07,"exercise_date":"2015-03-05","expiration_date":"2024-03-05","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-052883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919119052883/doc4.xml","form_type":"4"}},{"id":3395222,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-09T20:40:59.000Z","date":"2019-10-08","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 8, 2019, Rook Merger Sub, Inc. (\"Purchaser\"), a wholly owned subsidiary of Austin, Nichols & Co., Inc. (\"Parent\"), successfully completed the tender offer (\"Tender Offer\") for all issued and outstanding shares of the common stock of Castle Brands Inc. (\"Issuer\") pursuant to that certain Agreement and Plan of Merger, dated August 28, 2019 (the \"Merger Agreement\"), by and among Issuer, Parent and Purchaser. Following the Tender Offer, on October 9, 2019, Purchaser merged with and into Issuer with Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, the reporting person is no longer a director of Issuer, effective on October 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, this stock option held by the reporting person was deemed to be fully vested and cancelled and converted at the effective time of the Merger into the right to receive a cash payment, without interest, equal to the product of (i) the aggregate number of shares of the Issuer's Common Stock subject to such stock option multiplied by (ii) the excess of $1.27 over the per share exercise price of such stock option, less any taxes required to be withheld."}],"balance_after":0,"derivative":{"exercise_price":0.29,"exercise_date":"2013-10-15","expiration_date":"2022-10-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-052883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919119052883/doc4.xml","form_type":"4"}},{"id":3395221,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-09T20:40:59.000Z","date":"2019-10-08","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 8, 2019, Rook Merger Sub, Inc. (\"Purchaser\"), a wholly owned subsidiary of Austin, Nichols & Co., Inc. (\"Parent\"), successfully completed the tender offer (\"Tender Offer\") for all issued and outstanding shares of the common stock of Castle Brands Inc. (\"Issuer\") pursuant to that certain Agreement and Plan of Merger, dated August 28, 2019 (the \"Merger Agreement\"), by and among Issuer, Parent and Purchaser. Following the Tender Offer, on October 9, 2019, Purchaser merged with and into Issuer with Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, the reporting person is no longer a director of Issuer, effective on October 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, this stock option held by the reporting person was deemed to be fully vested and cancelled and converted at the effective time of the Merger into the right to receive a cash payment, without interest, equal to the product of (i) the aggregate number of shares of the Issuer's Common Stock subject to such stock option multiplied by (ii) the excess of $1.27 over the per share exercise price of such stock option, less any taxes required to be withheld."}],"balance_after":0,"derivative":{"exercise_price":0.27,"exercise_date":"2012-09-12","expiration_date":"2021-09-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-052883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919119052883/doc4.xml","form_type":"4"}},{"id":3395220,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-09T20:40:59.000Z","date":"2019-10-08","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 8, 2019, Rook Merger Sub, Inc. (\"Purchaser\"), a wholly owned subsidiary of Austin, Nichols & Co., Inc. (\"Parent\"), successfully completed the tender offer (\"Tender Offer\") for all issued and outstanding shares of the common stock of Castle Brands Inc. (\"Issuer\") pursuant to that certain Agreement and Plan of Merger, dated August 28, 2019 (the \"Merger Agreement\"), by and among Issuer, Parent and Purchaser. Following the Tender Offer, on October 9, 2019, Purchaser merged with and into Issuer with Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, the reporting person is no longer a director of Issuer, effective on October 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, this stock option held by the reporting person was deemed to be fully vested and cancelled and converted at the effective time of the Merger into the right to receive a cash payment, without interest, equal to the product of (i) the aggregate number of shares of the Issuer's Common Stock subject to such stock option multiplied by (ii) the excess of $1.27 over the per share exercise price of such stock option, less any taxes required to be withheld."}],"balance_after":0,"derivative":{"exercise_price":0.29,"exercise_date":"2011-02-04","expiration_date":"2020-02-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-052883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919119052883/doc4.xml","form_type":"4"}},{"id":3395219,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-09T20:40:59.000Z","date":"2019-10-08","kind":"disposition_to_issuer","acquired":false,"shares":22500,"price":1.27,"value":28575.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 8, 2019, Rook Merger Sub, Inc. (\"Purchaser\"), a wholly owned subsidiary of Austin, Nichols & Co., Inc. (\"Parent\"), successfully completed the tender offer (\"Tender Offer\") for all issued and outstanding shares of the common stock of Castle Brands Inc. (\"Issuer\") pursuant to that certain Agreement and Plan of Merger, dated August 28, 2019 (the \"Merger Agreement\"), by and among Issuer, Parent and Purchaser. Following the Tender Offer, on October 9, 2019, Purchaser merged with and into Issuer with Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, the reporting person is no longer a director of Issuer, effective on October 9, 2019."},{"field":"kind","element":"transactionCoding","label":"F3","text":"In accordance with the terms of the Merger Agreement, the restricted stock awards held by the reporting person were deemed to be fully vested and converted at the effective time of the Merger into the right to receive a cash payment, without interest, equal to the product of (i) the aggregate number of shares of the Issuer's Common Stock in respect of such restricted stock awards multiplied by (ii) $1.27, less any taxes required to be withheld."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-052883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919119052883/doc4.xml","form_type":"4"}},{"id":3395218,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-09T20:40:59.000Z","date":"2019-10-08","kind":"other","acquired":false,"shares":108500,"price":1.27,"value":137795.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 8, 2019, Rook Merger Sub, Inc. (\"Purchaser\"), a wholly owned subsidiary of Austin, Nichols & Co., Inc. (\"Parent\"), successfully completed the tender offer (\"Tender Offer\") for all issued and outstanding shares of the common stock of Castle Brands Inc. (\"Issuer\") pursuant to that certain Agreement and Plan of Merger, dated August 28, 2019 (the \"Merger Agreement\"), by and among Issuer, Parent and Purchaser. Following the Tender Offer, on October 9, 2019, Purchaser merged with and into Issuer with Issuer surviving the merger as a wholly owned subsidiary of Parent (the \"Merger\"). In connection with the Merger, the reporting person is no longer a director of Issuer, effective on October 9, 2019."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares tendered to the Purchaser in connection with the Tender Offer."}],"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001209191-19-052883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919119052883/doc4.xml","form_type":"4"}},{"id":3446722,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-06T00:17:20.000Z","date":"2019-08-01","kind":"grant","acquired":true,"shares":8334,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the vesting of 8,334 shares of the Performance Grant.  Following achievement of the Performance Criteria, the remaining 16,666 RSUs vest in two equal installments on July 1, 2020 and 2021, subject to accelerated vesting under certain conditions."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the vesting of 8,334 shares of the Performance Grant.  Following achievement of the Performance Criteria, the remaining 16,666 RSUs vest in two equal installments on July 1, 2020 and 2021, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 12,000 vested RSUs in which the reporting person has elected to defer delivery until the reporting person's separation of service from the issuer or death or disability."}],"balance_after":68472,"source":{"system":"sec-edgar","filing":"0001209191-19-044729","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000120919119044729/doc4.xml","form_type":"4"}},{"id":3446721,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-06T00:17:20.000Z","date":"2019-08-01","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"A performance grant of Restricted Stock Units (RSUs), which is convertible into common stock of the issuer on a one-for-one basis, was originally approved by the Company's Compensation Committee on September 5, 2018 (the \"Performance Grant\"), subject to the Performance Criteria described below, and reported on the Company's Form 8-K on September 10, 2018 and described in the Company's definitive proxy statement filed on April 16, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Performance Grant shall not vest unless and until the Company has, for any fiscal quarter through September 30, 2021 (i) gross revenue determined in accordance with the Company's reviewed or audited financial statements in excess of $7.0 million for such fiscal quarter, (ii) positive adjusted EBITDA, as determined based on the Company's reviewed or audited financial statements for such fiscal quarter, and (iii) the participant continues to provide services to the Company either as an employee, director or consultant on the last date of the quarter that the performance criteria is met (collectively, the \"Performance Criteria\"). If the Performance Criteria are met, the RSUs vest one-third annually on each of July 1, 2019, July 1, 2020 and July 1, 2021 (\"Time-Based Vesting Requirement\"). In the event of a change of control, all RSUs which have not vested on the date of such change of control shall immediately vest even if the Time-Based Vesting Requirement has not been met."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Performance Grant shall not vest unless and until the Company has, for any fiscal quarter through September 30, 2021 (i) gross revenue determined in accordance with the Company's reviewed or audited financial statements in excess of $7.0 million for such fiscal quarter, (ii) positive adjusted EBITDA, as determined based on the Company's reviewed or audited financial statements for such fiscal quarter, and (iii) the participant continues to provide services to the Company either as an employee, director or consultant on the last date of the quarter that the performance criteria is met (collectively, the \"Performance Criteria\"). If the Performance Criteria are met, the RSUs vest one-third annually on each of July 1, 2019, July 1, 2020 and July 1, 2021 (\"Time-Based Vesting Requirement\"). In the event of a change of control, all RSUs which have not vested on the date of such change of control shall immediately vest even if the Time-Based Vesting Requirement has not been met."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-19-044729","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000120919119044729/doc4.xml","form_type":"4"}},{"id":3469082,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-03T17:05:07.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning July 1, 2020."}],"balance_after":250000,"derivative":{"exercise_price":2.47,"expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-19-040730","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119040730/doc4.xml","form_type":"4"}},{"id":3479843,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2019-06-25T00:33:59.000Z","date":"2019-06-21","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 100% on June 21, 2020."}],"balance_after":20000,"derivative":{"exercise_price":3.8,"exercise_date":"2020-06-21","expiration_date":"2029-06-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-19-000794","document":"form4-06242019_050645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000141588919000794/form4-06242019_050645.xml","form_type":"4"}},{"id":3509082,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-29T21:12:00.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half (1/2) of the shares underlying the option shall vest on May 29, 2020 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":9.02,"expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-19-000622","document":"form4-05292019_020546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000622/form4-05292019_020546.xml","form_type":"4"}},{"id":3532195,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2019-05-10T10:16:01.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":7200,"price":2.15,"value":15480.0,"ownership":{"direct":true},"balance_after":5729147,"source":{"system":"sec-edgar","filing":"0001209191-19-028669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119028669/doc4.xml","form_type":"4"}},{"id":3532194,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2019-05-10T10:16:01.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":2600,"price":2.13,"value":5538.0,"ownership":{"direct":true},"balance_after":5721947,"source":{"system":"sec-edgar","filing":"0001209191-19-028669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119028669/doc4.xml","form_type":"4"}},{"id":3532193,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2019-05-10T10:16:01.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":200,"price":2.12,"value":424.0,"ownership":{"direct":true},"balance_after":5719347,"source":{"system":"sec-edgar","filing":"0001209191-19-028669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119028669/doc4.xml","form_type":"4"}},{"id":3606863,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2019-03-07T14:45:17.000Z","date":"2019-03-06","kind":"purchase","acquired":true,"shares":2435,"price":2.56,"value":6233.6,"ownership":{"direct":true},"balance_after":5719147,"source":{"system":"sec-edgar","filing":"0001209191-19-017607","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119017607/doc4.xml","form_type":"4"}},{"id":3606862,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2019-03-07T14:45:17.000Z","date":"2019-03-06","kind":"purchase","acquired":true,"shares":5565,"price":2.555,"value":14218.575,"ownership":{"direct":true},"balance_after":5716712,"source":{"system":"sec-edgar","filing":"0001209191-19-017607","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119017607/doc4.xml","form_type":"4"}},{"id":3622982,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-01T17:05:13.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted shares of common stock issued pursuant to the issuer's 2013 Incentive Compensation Plan, as amended. Restricted shares vest in two equal annual installments commencing on the first anniversary of the date of grant provided Mr. Rubin is then still a director of the issuer, subject to earlier vesting upon his death or disability or a change of control of the issuer."}],"balance_after":131000,"source":{"system":"sec-edgar","filing":"0001209191-19-015090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919119015090/doc4.xml","form_type":"4"}},{"id":3675470,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-05T21:33:18.000Z","date":"2019-02-01","kind":"exercise","acquired":false,"shares":24877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options were granted on February 5, 2009 and vested on February 5, 2010."}],"balance_after":0,"derivative":{"exercise_price":0.66,"exercise_date":"2010-02-05","expiration_date":"2019-02-04","underlying":"Common Stock","underlying_shares":24877},"source":{"system":"sec-edgar","filing":"0001209191-19-007353","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119007353/doc4.xml","form_type":"4"}},{"id":3675469,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2019-02-05T21:33:18.000Z","date":"2019-02-01","kind":"tax_withholding","acquired":false,"shares":5645,"price":3.59,"value":20265.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Company for payment of the tax liability in connection with the exercise of the stock option.  No shares of Common stock were sold by the reporting person in connection with this transaction.  The reporting person has retained the net number of shares issued upon the exercise of the option, less the amount retained to pay the associated tax liability (19,232 shares)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing market price of the Company's common stock on the transaction date."}],"balance_after":5711147,"source":{"system":"sec-edgar","filing":"0001209191-19-007353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119007353/doc4.xml","form_type":"4"}},{"id":3675468,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2019-02-05T21:33:18.000Z","date":"2019-02-01","kind":"exercise","acquired":true,"shares":24877,"price":0.66,"value":16418.82,"ownership":{"direct":true},"balance_after":5716792,"source":{"system":"sec-edgar","filing":"0001209191-19-007353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119007353/doc4.xml","form_type":"4"}},{"id":3691728,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-18T07:26:02.000Z","date":"2019-01-16","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested in four equal annual installments commencing on January 21, 2010."}],"balance_after":0,"derivative":{"exercise_price":0.23,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-004466","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919119004466/doc4.xml","form_type":"4"}},{"id":3691727,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-18T07:26:02.000Z","date":"2019-01-16","kind":"exercise","acquired":true,"shares":100000,"price":0.23,"value":23000.0,"ownership":{"direct":true},"balance_after":116000,"source":{"system":"sec-edgar","filing":"0001209191-19-004466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919119004466/doc4.xml","form_type":"4"}},{"id":3809002,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2018-09-24T20:49:48.000Z","date":"2018-09-21","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: 1/4 will vest on the one year anniversary of the grant date and the remaining 3/4 will vest in 12 equal quarterly increments."}],"balance_after":50000,"derivative":{"exercise_price":2.78,"expiration_date":"2028-09-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-18-013669","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315218013669/ownership.xml","form_type":"4"}},{"id":3882886,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-06-26T21:06:03.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 100% on June 22, 2019."}],"balance_after":20000,"derivative":{"exercise_price":3.83,"exercise_date":"2019-06-22","expiration_date":"2028-06-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-18-001026","document":"form4-06262018_020647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000141588918001026/form4-06262018_020647.xml","form_type":"4"}},{"id":3885435,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T20:13:07.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on June 21, 2018 and vest annually in four equal installments beginning on June 21, 2019."}],"balance_after":300000,"derivative":{"exercise_price":4.46,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-18-039171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118039171/doc4.xml","form_type":"4"}},{"id":3889185,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-19T22:24:07.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half (1/2) of the shares underlying the option shall vest on June 15, 2019 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":40000,"derivative":{"exercise_price":23.27,"expiration_date":"2028-06-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-038662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118038662/doc4.xml","form_type":"4"}},{"id":3891833,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (RSUs)","published_at":"2018-06-18T10:52:41.000Z","date":"2018-06-14","kind":"exercise","acquired":false,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest 1/3 per year annually over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest 1/3 per year annually over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date."}],"balance_after":18750,"derivative":{"underlying":"Common Shares","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001493152-18-008822","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218008822/form4.xml","form_type":"4"}},{"id":3891832,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value per share","published_at":"2018-06-18T10:52:41.000Z","date":"2018-06-14","kind":"exercise","acquired":true,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."}],"balance_after":56250,"source":{"system":"sec-edgar","filing":"0001493152-18-008822","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218008822/form4.xml","form_type":"4"}},{"id":3976059,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-02T11:57:36.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"On March 29, 2018, the reporting person received a grant of 8,000 RSUs, convertible into common stock of the issuer on a one-for-one basis.  The RSUs vest on March 29, 2019, subject to accelerated vesting under certain conditions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 29, 2018, the reporting person received a grant of 8,000 RSUs, convertible into common stock of the issuer on a one-for-one basis.  The RSUs vest on March 29, 2019, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 29, 2018, the reporting person received a grant of 8,000 RSUs, convertible into common stock of the issuer on a one-for-one basis.  The RSUs vest on March 29, 2019, subject to accelerated vesting under certain conditions."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-18-022260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000120919118022260/doc4.xml","form_type":"4"}},{"id":3976058,"issuer":{"id":4826,"kind":"organization","name":"Red Violet, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-02T11:57:36.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 29, 2018, the reporting person received a grant of 12,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis.  The RSUs vest in three equal installments on March 29, 2019, 2020 and 2021, subject to accelerated besting under certain conditions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 29, 2018, the reporting person received a grant of 12,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis.  The RSUs vest in three equal installments on March 29, 2019, 2020 and 2021, subject to accelerated besting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On March 29, 2018, the reporting person received a grant of 12,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis.  The RSUs vest in three equal installments on March 29, 2019, 2020 and 2021, subject to accelerated besting under certain conditions."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001209191-18-022260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000120919118022260/doc4.xml","form_type":"4"}},{"id":4006488,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2018-03-08T11:49:44.000Z","date":"2018-03-07","kind":"purchase","acquired":true,"shares":6000,"price":3.25,"value":19500.0,"ownership":{"direct":true},"balance_after":5691915,"source":{"system":"sec-edgar","filing":"0001209191-18-017888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118017888/doc4.xml","form_type":"4"}},{"id":4014633,"issuer":{"id":154496,"kind":"organization","name":"Castle Brands Inc","symbol":"ROX"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-05T17:06:32.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted shares of common stock issued pursuant to the issuer's 2013 Incentive Compensation Plan, as amended. Restricted shares vest in two equal annual installments commencing on the first anniversary of the date of grant provided Mr. Rubin is then still a director of the issuer, subject to earlier vesting upon his death or disability or a change of control of the issuer."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001209191-18-016614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1311538/000120919118016614/doc4.xml","form_type":"4"}},{"id":4090482,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Shares)","published_at":"2018-01-25T14:56:43.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 23, 2018 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 23, 2018 (the \"Option Agreement\"). The options vest and become exercisable in 36 equal monthly installments beginning on the first day of the month following the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":75000,"derivative":{"exercise_price":4.19,"expiration_date":"2028-01-23","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-18-001036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218001036/form4.xml","form_type":"4"}},{"id":4123895,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option (Right to Buy)","published_at":"2017-12-22T01:17:50.000Z","date":"2017-12-19","kind":"grant","acquired":true,"shares":43189,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Such options were granted to Mr. Rubin under Sevion Therapeutics Inc.'s (\"Sevion's\") 2008 Incentive Compensation Plan for services performed during Sevion's fiscal year ended June 30, 2017 and the portion of Sevion's fiscal year ended June 30, 2018 leading up to the closing of Sevion's transaction with Eloxx Pharmaceuticals, Ltd. (the \"Transaction\"), which occurred on December 19, 2017. In connection with closing of the Transaction, Sevion effected a 1-for-20 reverse stock split and changed its corporate name to \"Eloxx Pharmaceuticals, Inc.\" Such options were granted on a post-split basis and are immediately exercisable at an exercise price of $6.00 per share, which is equal to the closing selling price of Sevion's common stock on December 19, 2017, as reflected on a post-split basis."}],"balance_after":43189,"derivative":{"exercise_price":6,"exercise_date":"2017-12-19","expiration_date":"2027-12-19","underlying":"Common Stock","underlying_shares":43189},"source":{"system":"sec-edgar","filing":"0001144204-17-064887","document":"tv481924_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114420417064887/tv481924_4.xml","form_type":"4"}},{"id":4263472,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-07-05T22:14:24.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 100% on June 20, 2018."}],"balance_after":20000,"derivative":{"exercise_price":3.59,"exercise_date":"2018-06-20","expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-17-001123","document":"form4-07052017_030713.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1381874/000141588917001123/form4-07052017_030713.xml","form_type":"4"}},{"id":4280136,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (RSUs)","published_at":"2017-06-16T18:01:32.000Z","date":"2017-06-14","kind":"exercise","acquired":false,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest 1/3 per year over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date."}],"balance_after":37500,"derivative":{"expiration_date":"2026-06-14","underlying":"Common Shares","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001493152-17-006782","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217006782/form4.xml","form_type":"4"}},{"id":4280135,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value per share","published_at":"2017-06-16T18:01:32.000Z","date":"2017-06-14","kind":"exercise","acquired":true,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001493152-17-006782","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217006782/form4.xml","form_type":"4"}},{"id":4298593,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2017-06-01T13:27:54.000Z","date":"2017-05-31","kind":"purchase","acquired":true,"shares":2000,"price":6.1,"value":12200.0,"ownership":{"direct":true},"balance_after":5685915,"source":{"system":"sec-edgar","filing":"0001209191-17-036632","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117036632/doc4.xml","form_type":"4"}},{"id":4325520,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2017-05-11T18:17:33.000Z","date":"2017-05-11","kind":"purchase","acquired":true,"shares":1419,"price":6.91,"value":9805.29,"ownership":{"direct":true},"balance_after":5683915,"source":{"system":"sec-edgar","filing":"0001209191-17-031490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117031490/doc4.xml","form_type":"4"}},{"id":4325519,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2017-05-11T18:17:33.000Z","date":"2017-05-11","kind":"purchase","acquired":true,"shares":581,"price":6.9,"value":4008.9,"ownership":{"direct":true},"balance_after":5682496,"source":{"system":"sec-edgar","filing":"0001209191-17-031490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117031490/doc4.xml","form_type":"4"}},{"id":4351496,"issuer":{"id":6736,"kind":"organization","name":"Fluent, Inc.","symbol":"FLNT"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T20:39:29.000Z","date":"2017-04-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Within 30 days of the effective grant date, the reporting person may elect to defer delivery of any vested RSUs until a later date."},{"field":"security","element":"securityTitle","label":"F3","text":"On April 13, 2017, the reporting person received a grant of 5,000 RSUs, convertible into common stock of the issuer on a one-for-one basis.  The restricted stock units vest on June 1, 2017, subject to accelerated vesting under certain conditions."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On April 13, 2017, the reporting person received a grant of 5,000 RSUs, convertible into common stock of the issuer on a one-for-one basis.  The restricted stock units vest on June 1, 2017, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On April 13, 2017, the reporting person received a grant of 5,000 RSUs, convertible into common stock of the issuer on a one-for-one basis.  The restricted stock units vest on June 1, 2017, subject to accelerated vesting under certain conditions."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-17-027058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1460329/000120919117027058/doc4.xml","form_type":"4"}},{"id":4351495,"issuer":{"id":6736,"kind":"organization","name":"Fluent, Inc.","symbol":"FLNT"},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T20:39:29.000Z","date":"2017-04-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On April 13, 2017, the reporting person received a grant of 20,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis.  The RSUs vest in three approximately equal installments on June 1, 2017, 2018 and 2019, subject to accelerated vesting under certain conditions."},{"field":"security","element":"securityTitle","label":"F2","text":"Within 30 days of the effective grant date, the reporting person may elect to defer delivery of any vested RSUs until a later date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 13, 2017, the reporting person received a grant of 20,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis.  The RSUs vest in three approximately equal installments on June 1, 2017, 2018 and 2019, subject to accelerated vesting under certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On April 13, 2017, the reporting person received a grant of 20,000 restricted stock units (\"RSUs\"), convertible into common stock of the issuer on a one-for-one basis.  The RSUs vest in three approximately equal installments on June 1, 2017, 2018 and 2019, subject to accelerated vesting under certain conditions."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-17-027058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460329/000120919117027058/doc4.xml","form_type":"4"}},{"id":4352918,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-13T20:25:34.000Z","date":"2017-04-12","kind":"exercise","acquired":false,"shares":265000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options were granted on April 14, 2010 and vest in four equal installments beginning on April 14, 2011."}],"balance_after":0,"derivative":{"exercise_price":2.36,"expiration_date":"2017-04-13","underlying":"Common Stock","underlying_shares":265000},"source":{"system":"sec-edgar","filing":"0001209191-17-026862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117026862/doc4.xml","form_type":"4"}},{"id":4352917,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":25378,"kind":"person","name":"Rubin Steven D","position":1,"cik":"0001381874","reported_name":"Rubin Steven D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP-Administration"}}],"security":"Common Stock","published_at":"2017-04-13T20:25:34.000Z","date":"2017-04-12","kind":"tax_withholding","acquired":false,"shares":158336,"price":7.66,"value":1212853.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Company at the direction of the reporting person for payment of the exercise price and tax liability in connection with the exercise of the stock option.  No shares of Common stock were sold by the reporting person in connection with this transaction.  The reporting person has retained the net number of shares issued upon the exercise of the option, less the amount retained to pay the associated tax liability (106,664 of shares)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing market price of the Company's common stock on the transaction date."}],"balance_after":5681915,"source":{"system":"sec-edgar","filing":"0001209191-17-026862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117026862/doc4.xml","form_type":"4"}}],"next_cursor":"2017-04-13T20:25:34.000000Z,4352917"}